Trial Profile
A phase II trial of NRX-1074 as monotherapy in adult patients with Major Depressive Disorder
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2015
Price :
$35
*
At a glance
- Drugs Apimostinel (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- 06 Nov 2015 New trial record